![](https://investorshub.advfn.com/uicon/531063.png?cb=1466517003)
Tuesday, November 24, 2015 7:18:12 PM
Right now I am deep in the money on HPTG spectacular trading day on Tuesday. I went in on both HPTG and GOVX in the first half of 2014 after an alert of a stock analyst and gave a detailed fundamental analysis. Both comps. were poorly financed but had great products distictiv from their competitors and have patented their technologies.
Recently we can see strong financial improvements at HPTG, why? Because in the contrary of retail investors the institutional ones get the info. They don't spent a few 100K's to a microcap without getting an outlook of their invested money and returns.
You invest when the traders are pestimistic and the comp. gets barely attention. I am convinced that on the long run and yes this can take multiple years people will recognize quality products/ services starting with institutional investors. Ones this money enters the comp. accelerations are to be expected.
For HPTG: retrofitting of old diesel engines, diesel gate is the catalyst for stricter environmental regulations both in the USA as in Europe. For years big carcomps. have frustrated stricter regulations on testing exhaust fumes with a powerfull lobby.
For GOVX?:
Trust your doctor, but not the pills he prescribes, says the Danish professor Peter Gotzsche, which documented in a book the "rotten through and through 'suing pharmaceutical industry.
http://www.volkskrant.nl/wetenschap/vertrouw-de-arts-maar-niet-de-pil-die-hij-voorschrijft~a4191213/?utm_source=twitter&utm_content=free&utm_medium=social&hash=8ea610e1c98963237954dc6643ea03abed3e356b&utm_campaign=shared%20content
Link above is a dutch newspaper. Here in the Netherlands the ministre of healthcare is getting more and more aggitated by the attitude of the big biotech comps. for being so greedy and corrupt. In the Netherlands, health insurance companies make drugs at much lower costs. These are drugs whose patent has expired.
If and when a political landslide occurs I am sure that investors will be all over it.
Still need to do my dd if you have some links and/ or important info about GOVX I would appreciate that.
Recent GOVX News
- GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine • GlobeNewswire Inc. • 04/04/2024 04:30:00 PM
- GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress • GlobeNewswire Inc. • 03/28/2024 01:00:00 PM
- GeoVax to Present at the 36th Annual Roth Conference • GlobeNewswire Inc. • 03/12/2024 01:00:00 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 03/11/2024 08:13:14 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/11/2024 04:15:24 AM
- GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System • GlobeNewswire Inc. • 03/06/2024 02:00:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/01/2024 09:08:47 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 09:05:14 PM
- GeoVax Reports 2023 Year-End Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/29/2024 09:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 09:41:26 PM
- GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024 • GlobeNewswire Inc. • 02/22/2024 02:00:00 PM
- GeoVax to Present at the 2024 BIO CEO & Investor Conference • GlobeNewswire Inc. • 02/19/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:01:35 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:38:25 PM
- GeoVax Announces Multiple Patent Issuances and Allowances • GlobeNewswire Inc. • 02/13/2024 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:43:48 PM
- GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster • GlobeNewswire Inc. • 02/06/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 06:13:27 PM
- GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement • GlobeNewswire Inc. • 01/29/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 09:03:40 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/12/2024 09:00:38 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM